Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas

ClinicalTrials.gov ID: NCT01956474

Public ClinicalTrials.gov record NCT01956474. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 12:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas

Study identification

NCT ID
NCT01956474
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cxlusa
Industry
Enrollment
1,324 participants

Conditions and interventions

Conditions

Interventions

  • Theralight crosslinking and Riboflavin Other

Other

Eligibility (public fields only)

Age range
8 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2012
Primary completion
Feb 2, 2017
Completion
Feb 2, 2017
Last update posted
Oct 11, 2018

2013 – 2017

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Center for Excellence in Eye Care Miami Florida 33176
Stulting Research Center at Woolfson Eye Institute Atlanta Georgia 30328
TLC Laser Eye Center Rockville Maryland 20852
Talamo Hatch Laser Eye Consultants, LLC Boston Massachusetts 02451
Cleveland Eye Clinic Brecksville Ohio 44141
TLC Laser Eye Center Fairfax Virginia 22031

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01956474, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01956474 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →